What users say
0 votes
Usefulness
No data
0 votes
Value for Cost
No data
0 votes
Support
No data
0 votes
Pricing
No data
0 votes
Learning Curve
No data
0 votes
Paid on Platform
No data
0 votes
Rate this Tool
Related Moonlites
Related Creators
Related Education
PathAI is a revolutionary digital pathology platform that uses deep learning and computer vision to assist pathologists in diagnosing diseases from tissue samples and medical images. The platform analyzes pathology slides with AI-powered algorithms to detect cancer, predict treatment responses, and identify biomarkers that guide personalized therapy decisions. PathAI's machine learning models are trained on vast datasets of annotated pathology images, enabling accurate detection of breast cancer, prostate cancer, colorectal cancer, and other malignancies with clinical-grade precision. Key features include automated slide scanning and digitization, AI-powered cancer detection and grading, biomarker analysis for precision medicine, quality assurance tools for pathology labs, and integration with laboratory information management systems (LIMS). The platform supports pathologists with decision support tools that highlight areas of concern, provide diagnostic confidence scores, and accelerate case review workflows. PathAI's technology has been validated in multiple clinical trials and is used by leading cancer centers, pharmaceutical companies, and diagnostic laboratories worldwide. Popular among pathologists, oncologists, research laboratories, and pharmaceutical companies for accelerating cancer diagnosis, drug development, and precision medicine initiatives. The platform represents a significant advancement in computational pathology, making AI-assisted diagnosis accessible and reliable for clinical practice.
About
PathAI is a revolutionary digital pathology platform that uses deep learning and computer vision to assist pathologists in diagnosing diseases from tissue samples and medical images. The platform analyzes pathology slides with AI-powered algorithms to detect cancer, predict treatment responses, and identify biomarkers that guide personalized therapy decisions. PathAI's machine learning models are trained on vast datasets of annotated pathology images, enabling accurate detection of breast cancer, prostate cancer, colorectal cancer, and other malignancies with clinical-grade precision. Key features include automated slide scanning and digitization, AI-powered cancer detection and grading, biomarker analysis for precision medicine, quality assurance tools for pathology labs, and integration with laboratory information management systems (LIMS). The platform supports pathologists with decision support tools that highlight areas of concern, provide diagnostic confidence scores, and accelerate case review workflows. PathAI's technology has been validated in multiple clinical trials and is used by leading cancer centers, pharmaceutical companies, and diagnostic laboratories worldwide. Popular among pathologists, oncologists, research laboratories, and pharmaceutical companies for accelerating cancer diagnosis, drug development, and precision medicine initiatives. The platform represents a significant advancement in computational pathology, making AI-assisted diagnosis accessible and reliable for clinical practice.